BioLineRx (BLRX) Cash from Investing Activities Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.32% |
| Sep 30, 2025 | -13.40% |
| Jun 30, 2025 | 7.96% |
| Mar 31, 2025 | -27.13% |
| Dec 31, 2024 | 28.45% |
| Sep 30, 2024 | 14.42% |
| Jun 30, 2024 | -27.70% |
| Mar 31, 2024 | 30.55% |
| Dec 31, 2023 | -25.92% |
| Sep 30, 2023 | -4.75% |
| Jun 30, 2023 | 32.79% |
| Mar 31, 2023 | -3.85% |
| Dec 31, 2022 | 1.39% |
| Sep 30, 2022 | -33.42% |
| Jun 30, 2022 | 20.85% |
| Mar 31, 2022 | 29.86% |
| Dec 31, 2021 | 15.05% |
| Sep 30, 2021 | -58.17% |
| Jun 30, 2021 | -34.28% |
| Mar 31, 2021 | -88.70% |
| Dec 31, 2020 | 22.43% |
| Sep 30, 2020 | 61.70% |
| Jun 30, 2020 | -31.98% |
| Mar 31, 2020 | 18.12% |
| Dec 31, 2019 | 22.66% |
| Sep 30, 2019 | 105.43% |
| Jun 30, 2019 | 11.54% |
| Mar 31, 2019 | 13.34% |
| Dec 31, 2018 | -76.79% |
| Sep 30, 2018 | 39.96% |
| Jun 30, 2018 | -15.09% |
| Mar 31, 2018 | 21.73% |